Andrey Ugolkov, Devalingam Mahalingam, Rachna T. Shroff, Benedito A. Carneiro, Andrew L. Coveler, Andres Cervantes, Vaibhav Sahai, Anne Ploquin, Sandrine Hiret, Noelle K. LoConte, Charles D. Lopez, Simon Pernot, Petr Kavan, Mary Frances Mulcahy, Ryan Michael Carr, Francis J. Giles, Sheri Lynn Smith, Mark Jaros, Tanios S. Bekaii-Saab, Andrew Paul Mazar. "Mutational analysis and identification of potential biomarkers in patients with metastatic pancreatic cancer treated with the combination of the GSK-3 inhibitor elraglusib and gemcitabine/nab-paclitaxel in the 1801 Part 3B phase 2 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.761